ebomi
Colour theme
Sign in
Insider · CIK 0001258394

Mignone Roberto

CIK 0001258394 Name as filed on the most recent filing

Filed as Mignone Roberto (25)

28 transaction lines · from 25 filings · filed 2007-08-23 to 2025-12-18 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

8 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-12-16 S, Open-market sale Teva Pharmaceutical Industries LtdTEVA 2,340,646, disposed Open Form 4 filing 0001193125-25-324780
2025-11-26 S, Open-market sale Teva Pharmaceutical Industries LtdTEVA 1,301,505, disposed Open Form 4 filing 0001193125-25-303849
2025-11-06 S, Open-market sale Teva Pharmaceutical Industries LtdTEVA 4,821,880, disposed Open Form 4 filing 0001193125-25-274286
2024-12-20 S, Open-market sale Teva Pharmaceutical Industries LtdTEVA 6,294,031, disposed Open Form 4 filing 0000950170-24-140391
2024-06-18 S, Open-market sale Teva Pharmaceutical Industries LtdTEVA 8,838,570, disposed Open Form 4 filing 0000950170-24-076225
2020-10-01 P, Open-market purchase Avanti Acquisition Corp.AVAN 10,000,000, acquired Open Form 4 filing 0000899243-20-027310
2018-05-10 P, Open-market purchase Teva Pharmaceutical Industries LtdTEVA 4,829,700, acquired Open Form 4 filing 0001209191-18-029534
2018-05-09 P, Open-market purchase Teva Pharmaceutical Industries LtdTEVA 9,603,150, acquired Open Form 4 filing 0001209191-18-029534
2016-11-11 P, Open-market purchase Trovagene, Inc.TROV 993,214, disposed Open Form 4 filing 0001140361-16-086749
2015-07-17 P, Open-market purchase Trovagene, Inc.TROV 1,225,000, acquired Open Form 4 filing 0001140361-15-028172
2015-04-02 P, Open-market purchase Trovagene, Inc.TROV 2,070,000, acquired Open Form 4 filing 0001140361-15-014543
2015-02-27 P, Open-market purchase Trovagene, Inc.TROV 445,908, acquired Open Form 4 filing 0001140361-15-009491
2015-02-26 P, Open-market purchase Trovagene, Inc.TROV 427,101, acquired Open Form 4 filing 0001140361-15-009491
2015-02-25 P, Open-market purchase Trovagene, Inc.TROV 538,327, acquired Open Form 4 filing 0001140361-15-009491
2015-02-06 P, Open-market purchase Trovagene, Inc.TROV 1,999,998, acquired Open Form 4 filing 0001140361-15-005139
2012-09-13 P, Open-market purchase Response Genetics IncRGDX 3,300,000, acquired Open Form 4 filing 0001181431-12-050719
2009-10-08 S, Open-market sale Trimeris IncTRMS 7,550,588, disposed Open Form 4 filing 0001181431-09-047559
2008-12-12 P, Open-market purchase Orchid Cellmark IncORCH 594,822, acquired Open Form 4 filing 0001181431-08-067672
2008-04-14 P, Open-market purchase Jazz Pharmaceuticals IncJAZZ 84,192, acquired Open Form 4 filing 0001144204-08-022790
2008-04-11 P, Open-market purchase Jazz Pharmaceuticals IncJAZZ 90,618, acquired Open Form 4 filing 0001144204-08-022507
2008-04-10 P, Open-market purchase Jazz Pharmaceuticals IncJAZZ 20,919, acquired Open Form 4 filing 0001144204-08-021994
2008-04-08 P, Open-market purchase Jazz Pharmaceuticals IncJAZZ 2,544, acquired Open Form 4 filing 0001144204-08-021532
2008-04-07 P, Open-market purchase Jazz Pharmaceuticals IncJAZZ 232,495, acquired Open Form 4 filing 0001144204-08-021393
2008-04-04 P, Open-market purchase Jazz Pharmaceuticals IncJAZZ 13,110, acquired Open Form 4 filing 0001144204-08-021211
2008-04-03 P, Open-market purchase Jazz Pharmaceuticals IncJAZZ 65,179, acquired Open Form 4 filing 0001144204-08-020923
2008-04-02 P, Open-market purchase Jazz Pharmaceuticals IncJAZZ 356,408, acquired Open Form 4 filing 0001144204-08-020643
2008-03-14 P, Open-market purchase Jazz Pharmaceuticals IncJAZZ 9, acquired Open Form 4 filing 0001144204-08-016223
2007-08-21 P, Open-market purchase Trimeris IncTRMS 70,567, acquired Open Form 4 filing 0001144204-07-046221

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 3
  • Open-market sale 5
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. MIGNONE ROBERTO, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001258394

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.